Roche pulls a Gavreto approval before Blueprint severance, citing unfeasible trial

Roche pulls a Gavreto approval before Blueprint severance, citing unfeasible trial

Submitted by admin on July 5, 2023 - 7:12pm
Source: 
Fierce Pharma
News Tags: 
Roche
Blueprint Medicines
cancer
Gavreto
accelerated approvals
FDA
Headline: 
Roche pulls a Gavreto approval before Blueprint severance, citing unfeasible trial
snippet: 

Another FDA accelerated approval has run its course, with Roche giving up on a niche indication for cancer drug Gavreto.

Do Not Allow Advertisers to Use My Personal information